B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity-Reference-Cited by-同舟云学术

B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity

Published:2000-06 Issue:12 Volume:7 Page:993-999
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Paul DB,Barth RF,Yang W,Shen G-H,Kim J,Triozzi PL

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3301209.pdf

Reference41 articles.

1. Schultze J, Nadler LM, Gribben JG . B7-mediated costimulation and the immune response Blood Rev 1996 10: 111–127

2. Schwartz RH . Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy Cell 1992 71: 1065–1068

3. Chambers CA et al. The role of CTLA-4 in the regulation and initiation of T-cell responses Immunol Rev 1996 153: 27–46

4. Chen L et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 Cell 1992 71: 1093–1102

5. Chen L et al. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum Cancer Res 1994 54: 5420–5423

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research;Journal of Neuropathology & Experimental Neurology;2022-04-21

2. Immune Checkpoint Blockade – How Does It Work in Brain Metastases?;Frontiers in Molecular Neuroscience;2019-11-21

3. Preclinical Immunotherapeutic Animal Models for Brain Tumors;Translational Immunotherapy of Brain Tumors;2017

4. Toca 511 plus 5-fluorocytosine in combination with lomustine shows chemotoxic and immunotherapeutic activity with no additive toxicity in rodent glioblastoma models;Neuro-Oncology;2016-05-10

5. Split Immunity: Immune Inhibition of Rat Gliomas by Subcutaneous Exposure to Unmodified Live Tumor Cells;The Journal of Immunology;2011-10-12